Implementing PAT for successful Development of Biopharmaceuticals in the UK
Lead Participant:
GLAXOSMITHKLINE PLC
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| GLAXOSMITHKLINE PLC | £1,671,735 | £ 265,806 |
Participant |
||
| UNIVERSITY OF NEWCASTLE | £319,064 | £ 319,064 |
| UNIVERSITY OF STRATHCLYDE | £447,673 | £ 447,673 |
| UNIVERSITY OF LIVERPOOL | £238,099 | £ 238,099 |
People |
ORCID iD |